Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Mechanisms of Hormonal Control of Spermatogenesis in Man

Trial Profile

Mechanisms of Hormonal Control of Spermatogenesis in Man

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 30 Oct 2018

At a glance

  • Drugs Testosterone (Primary) ; Acyline; Chorionic gonadotropin; Dutasteride; Ketoconazole
  • Indications Hypogonadism
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Oct 2018 Planned End Date changed from 1 Dec 2025 to 1 Dec 2026.
    • 22 Oct 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2021.
    • 22 Oct 2018 Planned initiation date changed from 1 Jun 2018 to 1 Jun 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top